VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q42807736  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000253.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q42807736‏
024 ‎‡a  0000-0001-5939-1155‏ ‎‡2  orcid‏
024 ‎‡a  55471996200‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q42807736‏
100 0 ‎‡a  مايك توماس‏ ‎‡9  ar‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  Mike Thomas‏ ‎‡9  ast‏ ‎‡9  it‏ ‎‡9  sl‏ ‎‡9  es‏
400 0 ‎‡a  মাইক টমাস‏ ‎‡c  গবেষক‏ ‎‡9  bn‏
400 0 ‎‡a  Mike Thomas‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Mike Thomas‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
400 0 ‎‡a  Майк Томас‏ ‎‡9  ru‏
670 ‎‡a  Author's A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma‏
670 ‎‡a  Author's A new perspective on concepts of asthma severity and control.‏
670 ‎‡a  Author's A real-life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary care‏
670 ‎‡a  Author's A systematic review of psychological, physical health factors, and quality of life in adult asthma‏
670 ‎‡a  Author's Adult acute rhinosinusitis‏
670 ‎‡a  Author's Allergic rhinitis: evidence for impact on asthma‏
670 ‎‡a  Author's Alternative therapies for asthma: are patients at risk?‏
670 ‎‡a  Author's An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice‏
670 ‎‡a  Author's Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigm.‏
670 ‎‡a  Author's Asthma and panic: scope for intervention?‏
670 ‎‡a  Author's Asthma diagnosis: not always simple or straightforward….‏
670 ‎‡a  Author's Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis‏
670 ‎‡a  Author's Atopic wheezing and early life antibiotic exposure: a nested case-control study‏
670 ‎‡a  Author's Breaking new ground: challenging existing asthma guidelines‏
670 ‎‡a  Author's Burden of concomitant allergic rhinitis in adults with asthma‏
670 ‎‡a  Author's Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care‏
670 ‎‡a  Author's Cluster analysis and clinical asthma phenotypes.‏
670 ‎‡a  Author's Community-acquired pneumonia mortality: a potential link to antibiotic prescribing trends in general practice.‏
670 ‎‡a  Author's COPD exacerbation frequency, pharmacotherapy and resource use: an observational study in UK primary care‏
670 ‎‡a  Author's COPD overdiagnosis in primary care: a UK observational study of consistency of airflow obstruction‏
670 ‎‡a  Author's Correlation between perceived asthma control and thoraco-abdominal asynchrony in primary care patients diagnosed with asthma‏
670 ‎‡a  Author's Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma‏
670 ‎‡a  Author's Current control and future risk in asthma management‏
670 ‎‡a  Author's Current evidence and future research needs for FeNO measurement in respiratory diseases‏
670 ‎‡a  Author's Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections?‏
670 ‎‡a  Author's Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults‏
670 ‎‡a  Author's Evaluating the effectiveness of asthma treatment in real-life practice‏
670 ‎‡a  Author's Gastroesophageal reflux disease and asthma: a longitudinal study in UK general practice‏
670 ‎‡a  Author's GOLD COPD categories are not fit for purpose in primary care.‏
670 ‎‡a  Author's 'Help for Hay Fever', a goal-focused intervention for people with intermittent allergic rhinitis, delivered in Scottish community pharmacies: study protocol for a pilot cluster randomized controlled trial‏
670 ‎‡a  Author's Improvement of asthma control with a breath-actuated pressurised metred dose inhaler‏
670 ‎‡a  Author's Improvement of asthma control with a breath-actuated pressurised metred dose inhaler (BAI): a prescribing claims study of 5556 patients using a traditional pressurised metred dose inhaler (MDI) or a breath-actuated device.‏
670 ‎‡a  Author's Improving primary care management of asthma: do we know what really works?‏
670 ‎‡a  Author's Improving the appropriateness of laboratory submissions for urinalysis from general practice‏
670 ‎‡a  Author's Integrating real-life studies in the global therapeutic research framework.‏
670 ‎‡a  Author's Interactive workshops increase chlamydia testing in primary care--a controlled study‏
670 ‎‡a  Author's LETTER TO THE EDITOR‏
670 ‎‡a  Author's Managing patients with stable respiratory disease planning air travel: a primary care summary of the British Thoracic Society recommendations.‏
670 ‎‡a  Author's Mixed methods process evaluation of my breathing matters, a digital intervention to support self-management of asthma‏
670 ‎‡a  Author's No room to breathe: the importance of lung hyperinflation in COPD.‏
670 ‎‡a  Author's Patients' perceptions of the potential of breathing training for asthma: a qualitative study.‏
670 ‎‡a  Author's Precision medicine in airway diseases: moving to clinical practice‏
670 ‎‡a  Author's Prescribing and guidelines: both must improve to combat antimicrobial resistance‏
670 ‎‡a  Author's Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study‏
670 ‎‡a  Author's Prescribing trends in asthma: a longitudinal observational study‏
670 ‎‡a  Author's Primary care risk stratification in COPD using routinely collected data: a secondary data analysis‏
670 ‎‡a  Author's Prioritising the respiratory research needs of primary care: the International Primary Care Respiratory Group‏
670 ‎‡a  Author's Prioritising the respiratory research needs of primary care: the International Primary Care Respiratory Group (IPCRG) e-Delphi exercise.‏
670 ‎‡a  Author's Problems of basing patient recruitment for primary care studies on routine laboratory submissions‏
670 ‎‡a  Author's Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations.‏
670 ‎‡a  Author's Quality standards for real-world research. Focus on observational database studies of comparative effectiveness‏
670 ‎‡a  Author's Re: Symptomatic asthma: attendance and prescribing in general practice‏
670 ‎‡a  Author's Re: Symptomatic asthma: attendance and prescribing in general practice (Respir Med 96: 102-109): Critique of Nolan and White‏
670 ‎‡a  Author's Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma‏
670 ‎‡a  Author's Reevaluating Acupuncture Research Methods‏
670 ‎‡a  Author's Respiratory physiotherapy: towards a clearer definition of terminology‏
670 ‎‡a  Author's Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis‏
670 ‎‡a  Author's Single inhaler maintenance and reliever therapy‏
670 ‎‡a  Author's Single inhaler maintenance and reliever therapy (SMART) in general practice asthma management: where are we?‏
670 ‎‡a  Author's Suboptimal persistence with inhaled corticosteroid monotherapy among children with persistent asthma in the UK‏
670 ‎‡a  Author's Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST‏
670 ‎‡a  Author's The Brussels Declaration: the need for change in asthma management‏
670 ‎‡a  Author's The Help for Hay Fever community pharmacy-based pilot randomised controlled trial for intermittent allergic rhinitis‏
670 ‎‡a  Author's The importance of differentiating behavioural and psychological treatment effects from placebo in respiratory interventions‏
670 ‎‡a  Author's The national montelukast survey‏
670 ‎‡a  Author's The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data‏
670 ‎‡a  Author's The role of breathing training in asthma management‏
670 ‎‡a  Author's The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial‏
670 ‎‡a  Author's Treatment and outcomes in patients with asthma and allergic rhinitis in the United kingdom.‏
670 ‎‡a  Author's Using fractional exhaled nitric oxide to guide step-down treatment decisions in asthma: practical considerations‏
670 ‎‡a  Author's Using fractional exhaled nitric oxide to guide step down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis‏
670 ‎‡a  Author's What happens to patients who have their asthma device switched without their consent?‏
670 ‎‡a  Author's সম্পাদককে চিঠি‏
909 ‎‡a  (scopus) 55471996200‏ ‎‡9  1‏
909 ‎‡a  (orcid) 0000000159391155‏ ‎‡9  1‏
912 ‎‡a  lettertotheeditor‏ ‎‡A  LETTER TO THE EDITOR‏ ‎‡9  1‏
912 ‎‡a  rhinitisassociatedwithasthmaisdistinctfromrhinitisalonethescpariamedallscphypothesis‏ ‎‡A  Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis‏ ‎‡9  1‏
912 ‎‡a  সমপদককচঠ‏ ‎‡A  সম্পাদককে চিঠি‏ ‎‡9  1‏
919 ‎‡a  mixedmethodsprocessevaluationofmybreathingmattersadigitalinterventiontosupportselfmanagementofasthma‏ ‎‡A  Mixed methods process evaluation of my breathing matters, a digital intervention to support self-management of asthma‏ ‎‡9  1‏
919 ‎‡a  managingpatientswithstablerespiratorydiseaseplanningairtravelaprimarycaresummaryofthebritishthoracicsocietyrecommendations‏ ‎‡A  Managing patients with stable respiratory disease planning air travel: a primary care summary of the British Thoracic Society recommendations.‏ ‎‡9  1‏
919 ‎‡a  interactiveworkshopsincreasechlamydiatestinginprimarycareacontrolledstudy‏ ‎‡A  Interactive workshops increase chlamydia testing in primary care--a controlled study‏ ‎‡9  1‏
919 ‎‡a  integratingreallifestudiesintheglobaltherapeuticresearchframework‏ ‎‡A  Integrating real-life studies in the global therapeutic research framework.‏ ‎‡9  1‏
919 ‎‡a  improvingtheappropriatenessoflaboratorysubmissionsforurinalysisfromgeneralpractice‏ ‎‡A  Improving the appropriateness of laboratory submissions for urinalysis from general practice‏ ‎‡9  1‏
919 ‎‡a  prescribingandguidelinesbothmustimprovetocombatantimicrobialresistance‏ ‎‡A  Prescribing and guidelines: both must improve to combat antimicrobial resistance‏ ‎‡9  1‏
919 ‎‡a  improvingprimarycaremanagementofasthmadoweknowwhatreallyworks‏ ‎‡A  Improving primary care management of asthma: do we know what really works?‏ ‎‡9  1‏
919 ‎‡a  prescribingpatternsofasthmacontrollertherapyforchildreninukprimarycareacrosssectionalobservationalstudy‏ ‎‡A  Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study‏ ‎‡9  1‏
919 ‎‡a  improvementofasthmacontrolwithabreathactuatedpressurisedmetreddoseinhalerbaiaprescribingclaimsstudyof5556patientsusingatraditionalpressurisedmetreddoseinhaler1501orabreathactuateddevice‏ ‎‡A  Improvement of asthma control with a breath-actuated pressurised metred dose inhaler (BAI): a prescribing claims study of 5556 patients using a traditional pressurised metred dose inhaler (MDI) or a breath-actuated device.‏ ‎‡9  1‏
919 ‎‡a  improvementofasthmacontrolwithabreathactuatedpressurisedmetreddoseinhaler‏ ‎‡A  Improvement of asthma control with a breath-actuated pressurised metred dose inhaler‏ ‎‡9  1‏
919 ‎‡a  helpforhayfeveragoalfocusedinterventionforpeoplewithintermittentallergicrhinitisdeliveredinscottishcommunitypharmaciesstudyprotocolforapilotclusterrandomizedcontrolledtrial‏ ‎‡A  'Help for Hay Fever', a goal-focused intervention for people with intermittent allergic rhinitis, delivered in Scottish community pharmacies: study protocol for a pilot cluster randomized controlled trial‏ ‎‡9  1‏
919 ‎‡a  goldcopdcategoriesarenotfitforpurposeinprimarycare‏ ‎‡A  GOLD COPD categories are not fit for purpose in primary care.‏ ‎‡9  1‏
919 ‎‡a  gastroesophagealrefluxdiseaseandasthmaalongitudinalstudyinukgeneralpractice‏ ‎‡A  Gastroesophageal reflux disease and asthma: a longitudinal study in UK general practice‏ ‎‡9  1‏
919 ‎‡a  evaluatingtheeffectivenessofasthmatreatmentinreallifepractice‏ ‎‡A  Evaluating the effectiveness of asthma treatment in real-life practice‏ ‎‡9  1‏
919 ‎‡a  effectofaconcomitantdiagnosisofallergicrhinitisonasthmarelatedhealthcareusebyadults‏ ‎‡A  Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults‏ ‎‡9  1‏
919 ‎‡a  doeslaboratoryantibioticsusceptibilityreportinginfluenceprimarycareprescribinginurinarytractinfectionandotherinfections‏ ‎‡A  Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections?‏ ‎‡9  1‏
919 ‎‡a  currentevidenceandfutureresearchneedsforfenomeasurementinrespiratorydiseases‏ ‎‡A  Current evidence and future research needs for FeNO measurement in respiratory diseases‏ ‎‡9  1‏
919 ‎‡a  currentcontrolandfutureriskinasthmamanagement‏ ‎‡A  Current control and future risk in asthma management‏ ‎‡9  1‏
919 ‎‡a  costeffectivenessofsalmeterolxinafoatefluticasonepropionatecombinationinhalerinchronicasthma‏ ‎‡A  Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma‏ ‎‡9  1‏
919 ‎‡a  correlationbetweenperceivedasthmacontrolandthoracoabdominalasynchronyinprimarycarepatientsdiagnosedwithasthma‏ ‎‡A  Correlation between perceived asthma control and thoraco-abdominal asynchrony in primary care patients diagnosed with asthma‏ ‎‡9  1‏
919 ‎‡a  prescribingtrendsinasthmaalongitudinalobservationalstudy‏ ‎‡A  Prescribing trends in asthma: a longitudinal observational study‏ ‎‡9  1‏
919 ‎‡a  primarycareriskstratificationincopdusingroutinelycollecteddataasecondarydataanalysis‏ ‎‡A  Primary care risk stratification in COPD using routinely collected data: a secondary data analysis‏ ‎‡9  1‏
919 ‎‡a  prioritisingtherespiratoryresearchneedsofprimarycaretheinternationalprimarycarerespiratorygroup‏ ‎‡A  Prioritising the respiratory research needs of primary care: the International Primary Care Respiratory Group‏ ‎‡9  1‏
919 ‎‡a  prioritisingtherespiratoryresearchneedsofprimarycaretheinternationalprimarycarerespiratorygroupipcrgedelphiexercise‏ ‎‡A  Prioritising the respiratory research needs of primary care: the International Primary Care Respiratory Group (IPCRG) e-Delphi exercise.‏ ‎‡9  1‏
919 ‎‡a  problemsofbasingpatientrecruitmentforprimarycarestudiesonroutinelaboratorysubmissions‏ ‎‡A  Problems of basing patient recruitment for primary care studies on routine laboratory submissions‏ ‎‡9  1‏
919 ‎‡a  quadruplinginhaledglucocorticoiddosetoabortasthmaexacerbations‏ ‎‡A  Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations.‏ ‎‡9  1‏
919 ‎‡a  qualitystandardsforrealworldresearchfocusonobservationaldatabasestudiesofcomparativeeffectiveness‏ ‎‡A  Quality standards for real-world research. Focus on observational database studies of comparative effectiveness‏ ‎‡9  1‏
919 ‎‡a  resymptomaticasthmaattendanceandprescribingingeneralpractice‏ ‎‡A  Re: Symptomatic asthma: attendance and prescribing in general practice‏ ‎‡9  1‏
919 ‎‡a  resymptomaticasthmaattendanceandprescribingingeneralpracticerespirmed96102109critiqueofnolanandwhite‏ ‎‡A  Re: Symptomatic asthma: attendance and prescribing in general practice (Respir Med 96: 102-109): Critique of Nolan and White‏ ‎‡9  1‏
919 ‎‡a  reallifecomparisonofbeclometasonedipropionateasanextrafineorlargerparticleformulationforasthma‏ ‎‡A  Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma‏ ‎‡9  1‏
919 ‎‡a  reevaluatingacupunctureresearchmethods‏ ‎‡A  Reevaluating Acupuncture Research Methods‏ ‎‡9  1‏
919 ‎‡a  respiratoryphysiotherapytowardsaclearerdefinitionofterminology‏ ‎‡A  Respiratory physiotherapy: towards a clearer definition of terminology‏ ‎‡9  1‏
919 ‎‡a  singleinhalermaintenanceandrelievertherapy‏ ‎‡A  Single inhaler maintenance and reliever therapy‏ ‎‡9  1‏
919 ‎‡a  singleinhalermaintenanceandrelievertherapysmartingeneralpracticeasthmamanagementwherearewe‏ ‎‡A  Single inhaler maintenance and reliever therapy (SMART) in general practice asthma management: where are we?‏ ‎‡9  1‏
919 ‎‡a  suboptimalpersistencewithinhaledcorticosteroidmonotherapyamongchildrenwithpersistentasthmaintheuk‏ ‎‡A  Suboptimal persistence with inhaled corticosteroid monotherapy among children with persistent asthma in the UK‏ ‎‡9  1‏
919 ‎‡a  temporarilyquadruplingthedoseofinhaledsteroidtopreventasthmaexacerbationsfast‏ ‎‡A  Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST‏ ‎‡9  1‏
919 ‎‡a  brusselsdeclarationtheneedforchangeinasthmamanagement‏ ‎‡A  The Brussels Declaration: the need for change in asthma management‏ ‎‡9  1‏
919 ‎‡a  helpforhayfevercommunitypharmacybasedpilotrandomisedcontrolledtrialforintermittentallergicrhinitis‏ ‎‡A  The Help for Hay Fever community pharmacy-based pilot randomised controlled trial for intermittent allergic rhinitis‏ ‎‡9  1‏
919 ‎‡a  importanceofdifferentiatingbehaviouralandpsychologicaltreatmenteffectsfromplaceboinrespiratoryinterventions‏ ‎‡A  The importance of differentiating behavioural and psychological treatment effects from placebo in respiratory interventions‏ ‎‡9  1‏
919 ‎‡a  copdoverdiagnosisinprimarycareaukobservationalstudyofconsistencyofairflowobstruction‏ ‎‡A  COPD overdiagnosis in primary care: a UK observational study of consistency of airflow obstruction‏ ‎‡9  1‏
919 ‎‡a  copdexacerbationfrequencypharmacotherapyandresourceuseanobservationalstudyinukprimarycare‏ ‎‡A  COPD exacerbation frequency, pharmacotherapy and resource use: an observational study in UK primary care‏ ‎‡9  1‏
919 ‎‡a  nationalmontelukastsurvey‏ ‎‡A  The national montelukast survey‏ ‎‡9  1‏
919 ‎‡a  relationshipbetweenprimarycareantibioticprescribingandbacterialresistanceinadultsinthecommunityacontrolledobservationalstudyusingindividualpatientdata‏ ‎‡A  The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient data‏ ‎‡9  1‏
919 ‎‡a  roleofbreathingtraininginasthmamanagement‏ ‎‡A  The role of breathing training in asthma management‏ ‎‡9  1‏
919 ‎‡a  useofexhalednitricoxidetoguideasthmamanagementarandomizedcontrolledtrial‏ ‎‡A  The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial‏ ‎‡9  1‏
919 ‎‡a  treatmentandoutcomesinpatientswithasthmaandallergicrhinitisintheunitedkingdom‏ ‎‡A  Treatment and outcomes in patients with asthma and allergic rhinitis in the United kingdom.‏ ‎‡9  1‏
919 ‎‡a  usingfractionalexhalednitricoxidetoguidestepdowntreatmentdecisionsinasthmapracticalconsiderations‏ ‎‡A  Using fractional exhaled nitric oxide to guide step-down treatment decisions in asthma: practical considerations‏ ‎‡9  1‏
919 ‎‡a  usingfractionalexhalednitricoxidetoguidestepdowntreatmentdecisionsinpatientswithasthmaasystematicreviewandindividualpatientdatametaanalysis‏ ‎‡A  Using fractional exhaled nitric oxide to guide step down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis‏ ‎‡9  1‏
919 ‎‡a  whathappenstopatientswhohavetheirasthmadeviceswitchedwithouttheirconsent‏ ‎‡A  What happens to patients who have their asthma device switched without their consent?‏ ‎‡9  1‏
919 ‎‡a  communityacquiredpneumoniamortalityapotentiallinktoantibioticprescribingtrendsingeneralpractice‏ ‎‡A  Community-acquired pneumonia mortality: a potential link to antibiotic prescribing trends in general practice.‏ ‎‡9  1‏
919 ‎‡a  clusteranalysisandclinicalasthmaphenotypes‏ ‎‡A  Cluster analysis and clinical asthma phenotypes.‏ ‎‡9  1‏
919 ‎‡a  clinicalrelevanceoflaboratoryreportedantibioticresistanceinacuteuncomplicatedurinarytractinfectioninprimarycare‏ ‎‡A  Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care‏ ‎‡9  1‏
919 ‎‡a  burdenofconcomitantallergicrhinitisinadultswithasthma‏ ‎‡A  Burden of concomitant allergic rhinitis in adults with asthma‏ ‎‡9  1‏
919 ‎‡a  breakingnewgroundchallengingexistingasthmaguidelines‏ ‎‡A  Breaking new ground: challenging existing asthma guidelines‏ ‎‡9  1‏
919 ‎‡a  atopicwheezingandearlylifeantibioticexposureanestedcasecontrolstudy‏ ‎‡A  Atopic wheezing and early life antibiotic exposure: a nested case-control study‏ ‎‡9  1‏
919 ‎‡a  asthmarelatedhealthcareresourceuseamongasthmaticchildrenwithandwithoutconcomitantallergicrhinitis‏ ‎‡A  Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis‏ ‎‡9  1‏
919 ‎‡a  asthmadiagnosisnotalwayssimpleorstraightforward‏ ‎‡A  Asthma diagnosis: not always simple or straightforward….‏ ‎‡9  1‏
919 ‎‡a  asthmaandpanicscopeforintervention‏ ‎‡A  Asthma and panic: scope for intervention?‏ ‎‡9  1‏
919 ‎‡a  assessingtheriskofattackinthemanagementofasthmaareviewandproposalforrevisionofthecurrentcontrolcentredparadigm‏ ‎‡A  Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigm.‏ ‎‡9  1‏
919 ‎‡a  officialamericanthoracicsocietyeuropeanrespiratorysocietystatementasthmacontrolandexacerbationsstandardizingendpointsforclinicalasthmatrialsandclinicalpractice‏ ‎‡A  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice‏ ‎‡9  1‏
919 ‎‡a  alternativetherapiesforasthmaarepatientsatrisk‏ ‎‡A  Alternative therapies for asthma: are patients at risk?‏ ‎‡9  1‏
919 ‎‡a  allergicrhinitisevidenceforimpactonasthma‏ ‎‡A  Allergic rhinitis: evidence for impact on asthma‏ ‎‡9  1‏
919 ‎‡a  adultacuterhinosinusitis‏ ‎‡A  Adult acute rhinosinusitis‏ ‎‡9  1‏
919 ‎‡a  systematicreviewofpsychologicalphysicalhealthfactorsandqualityoflifeinadultasthma‏ ‎‡A  A systematic review of psychological, physical health factors, and quality of life in adult asthma‏ ‎‡9  1‏
919 ‎‡a  reallifecomparativeeffectivenessstudyintotheadditionofantibioticstothemanagementofasthmaexacerbationsinprimarycare‏ ‎‡A  A real-life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary care‏ ‎‡9  1‏
919 ‎‡a  newperspectiveonconceptsofasthmaseverityandcontrol‏ ‎‡A  A new perspective on concepts of asthma severity and control.‏ ‎‡9  1‏
919 ‎‡a  crosssectionalstudyofpatternsofairwaydysfunctionsymptomsandmorbidityinprimarycareasthma‏ ‎‡A  A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma‏ ‎‡9  1‏
919 ‎‡a  noroomtobreathetheimportanceoflunghyperinflationincopd‏ ‎‡A  No room to breathe: the importance of lung hyperinflation in COPD.‏ ‎‡9  1‏
919 ‎‡a  patientsperceptionsofthepotentialofbreathingtrainingforasthmaaqualitativestudy‏ ‎‡A  Patients' perceptions of the potential of breathing training for asthma: a qualitative study.‏ ‎‡9  1‏
919 ‎‡a  precisionmedicineinairwaydiseasesmovingtoclinicalpractice‏ ‎‡A  Precision medicine in airway diseases: moving to clinical practice‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  NTA|090888545‏
996 ‎‡2  CAOONL|ncf11514768‏
996 ‎‡2  LC|nb 99051821‏
996 ‎‡2  LC|n 95911359‏
996 ‎‡2  NUKAT|n 97037172‏
996 ‎‡2  ISNI|0000000029578499‏
996 ‎‡2  PLWABN|9810646684305606‏
996 ‎‡2  LC|no2014098660‏
996 ‎‡2  J9U|987007423964005171‏
996 ‎‡2  ISNI|000000049799141X‏
996 ‎‡2  NUKAT|n 2009129384‏
996 ‎‡2  CAOONL|ncf11402166‏
996 ‎‡2  LC|n 88649965‏
996 ‎‡2  J9U|987007386688905171‏
996 ‎‡2  LC|no2009199324‏
996 ‎‡2  BIBSYS|90208840‏
996 ‎‡2  ISNI|0000000077028635‏
996 ‎‡2  CAOONL|ncf11621413‏
996 ‎‡2  ISNI|0000000115451937‏
996 ‎‡2  LC|nb2021010042‏
996 ‎‡2  BIBSYS|11060505‏
996 ‎‡2  SUDOC|275555135‏
996 ‎‡2  LC|nb2009007922‏
996 ‎‡2  LC|nb2009007923‏
996 ‎‡2  BNF|13841557‏
996 ‎‡2  SUDOC|244266336‏
996 ‎‡2  PLWABN|9810652225005606‏
996 ‎‡2  NII|DA02139205‏
996 ‎‡2  BNF|13841558‏
996 ‎‡2  ISNI|0000000025679612‏
996 ‎‡2  LC|no2016116344‏
996 ‎‡2  LC|no2003077693‏
996 ‎‡2  ISNI|0000000117014255‏
996 ‎‡2  BNF|17728087‏
996 ‎‡2  PLWABN|9811515640305606‏
996 ‎‡2  SUDOC|081711050‏
996 ‎‡2  LC|no2016047629‏
996 ‎‡2  DNB|1054438781‏
996 ‎‡2  BNF|16612256‏
996 ‎‡2  SKMASNL|vtls012627357‏
996 ‎‡2  ISNI|0000000034275417‏
996 ‎‡2  ISNI|0000000043570135‏
996 ‎‡2  LC|no2023053321‏
996 ‎‡2  RERO|A016530776‏
996 ‎‡2  ISNI|0000000398491567‏
996 ‎‡2  LC|no2020066046‏
996 ‎‡2  BIBSYS|1000956‏
996 ‎‡2  DNB|127181350‏
996 ‎‡2  SUDOC|152942866‏
996 ‎‡2  LC|no2009183170‏
996 ‎‡2  LC|nr 99032962‏
996 ‎‡2  SUDOC|136275990‏
996 ‎‡2  NTA|269762930‏
996 ‎‡2  RERO|A012326119‏
996 ‎‡2  ISNI|0000000073895213‏
996 ‎‡2  NII|DA07165891‏
996 ‎‡2  CAOONL|ncf11613232‏
996 ‎‡2  LC|no2015042933‏
996 ‎‡2  ISNI|0000000496083153‏
996 ‎‡2  ISNI|000000001850665X‏
996 ‎‡2  DNB|121383261‏
996 ‎‡2  J9U|987007360681905171‏
996 ‎‡2  LC|n 88621188‏
996 ‎‡2  BNF|12729260‏
996 ‎‡2  BNF|15579693‏
996 ‎‡2  LC|n 2011059803‏
996 ‎‡2  BNF|14232883‏
996 ‎‡2  DNB|1019643072‏
996 ‎‡2  J9U|987007426374305171‏
996 ‎‡2  NUKAT|n 2006113978‏
996 ‎‡2  ISNI|0000000062511974‏
996 ‎‡2  NTA|355362953‏
996 ‎‡2  NUKAT|n 2008074330‏
996 ‎‡2  NTA|072104147‏
996 ‎‡2  NLA|000035546766‏
996 ‎‡2  NII|DA17616148‏
996 ‎‡2  DNB|121965449‏
996 ‎‡2  ISNI|0000000043029488‏
996 ‎‡2  SUDOC|08868508X‏
996 ‎‡2  LC|n 97032915‏
996 ‎‡2  DNB|1162292571‏
996 ‎‡2  ISNI|0000000054719513‏
996 ‎‡2  SUDOC|234602457‏
996 ‎‡2  PLWABN|9811801726505606‏
996 ‎‡2  DNB|1239090544‏
996 ‎‡2  CAOONL|ncf11639698‏
996 ‎‡2  DNB|1167412613‏
996 ‎‡2  NUKAT|n 2002086307‏
996 ‎‡2  DNB|173327257‏
996 ‎‡2  DNB|118819224‏
996 ‎‡2  LC|nb2016025688‏
996 ‎‡2  B2Q|0000828332‏
996 ‎‡2  LC|nr 94028463‏
996 ‎‡2  LC|nb2016019311‏
996 ‎‡2  CAOONL|ncf11893981‏
996 ‎‡2  SUDOC|076096025‏
996 ‎‡2  ISNI|0000000069148012‏
996 ‎‡2  BIBSYS|90128919‏
996 ‎‡2  BNF|14141030‏
996 ‎‡2  ISNI|000000040662608X‏
996 ‎‡2  LC|no2018015818‏
996 ‎‡2  SUDOC|128719540‏
996 ‎‡2  BNF|11926531‏
996 ‎‡2  DNB|173698204‏
996 ‎‡2  BNF|17790209‏
996 ‎‡2  SUDOC|03432500X‏
996 ‎‡2  CAOONL|ncf10942173‏
996 ‎‡2  CAOONL|ncf10942174‏
996 ‎‡2  CAOONL|ncf10942175‏
996 ‎‡2  LC|n 79085132‏
996 ‎‡2  NUKAT|n 2016081393‏
996 ‎‡2  PLWABN|9810581750805606‏
996 ‎‡2  ISNI|0000000046110783‏
996 ‎‡2  NUKAT|n 00013164‏
996 ‎‡2  BNE|XX1692152‏
996 ‎‡2  NTA|29218882X‏
996 ‎‡2  NUKAT|n 2013150059‏
996 ‎‡2  RERO|A009403969‏
996 ‎‡2  LC|n 82072838‏
996 ‎‡2  RERO|A018162255‏
996 ‎‡2  SUDOC|154989428‏
996 ‎‡2  LC|n 2008183783‏
996 ‎‡2  BIBSYS|3033761‏
996 ‎‡2  B2Q|0000318963‏
996 ‎‡2  BNF|12073314‏
996 ‎‡2  SUDOC|262283255‏
996 ‎‡2  DNB|137336314‏
996 ‎‡2  ISNI|0000000075221212‏
996 ‎‡2  ISNI|000000003364409X‏
996 ‎‡2  CAOONL|ncf11577541‏
996 ‎‡2  DNB|1030328064‏
996 ‎‡2  ISNI|0000000078341180‏
996 ‎‡2  NUKAT|n 2019104156‏
996 ‎‡2  LC|nb2001031570‏
996 ‎‡2  NUKAT|n 2006152770‏
996 ‎‡2  BNF|12642098‏
996 ‎‡2  LC|n 83055883‏
996 ‎‡2  ISNI|000000004250956X‏
996 ‎‡2  SUDOC|075027917‏
996 ‎‡2  NLA|000035687047‏
996 ‎‡2  ISNI|000000008006950X‏
996 ‎‡2  LC|n 2003129905‏
996 ‎‡2  ISNI|0000000029776487‏
996 ‎‡2  BIBSYS|11034447‏
996 ‎‡2  LC|no2017150644‏
996 ‎‡2  ISNI|0000000367099917‏
996 ‎‡2  BIBSYS|97055069‏
996 ‎‡2  BIBSYS|3040983‏
996 ‎‡2  LC|n 2017240453‏
996 ‎‡2  DBC|87097992319350‏
996 ‎‡2  BNF|12340630‏
996 ‎‡2  ISNI|0000000114169307‏
996 ‎‡2  BIBSYS|90970395‏
996 ‎‡2  DNB|128561866‏
996 ‎‡2  LC|n 83009865‏
996 ‎‡2  DNB|1055013288‏
996 ‎‡2  LC|nb2016014760‏
996 ‎‡2  LC|n 2017045890‏
996 ‎‡2  SUDOC|164303421‏
996 ‎‡2  LC|nr2007003011‏
996 ‎‡2  SUDOC|184960029‏
996 ‎‡2  LNB|LNC10-000032792‏
996 ‎‡2  LC|n 88621868‏
996 ‎‡2  J9U|987012330160205171‏
996 ‎‡2  NTA|395596955‏
996 ‎‡2  NUKAT|n 2017076501‏
996 ‎‡2  NTA|067969879‏
996 ‎‡2  NLA|000035218337‏
996 ‎‡2  ISNI|0000000108792901‏
996 ‎‡2  LC|n 98103121‏
996 ‎‡2  DNB|1033446793‏
996 ‎‡2  DNB|143239953‏
996 ‎‡2  NTA|168381338‏
996 ‎‡2  NII|DA01971151‏
996 ‎‡2  BNF|12509117‏
996 ‎‡2  ISNI|000000011238891X‏
996 ‎‡2  ISNI|0000000451336196‏
996 ‎‡2  NTA|07329005X‏
996 ‎‡2  LC|no2023078945‏
996 ‎‡2  BNF|13592724‏
996 ‎‡2  J9U|987009908779005171‏
996 ‎‡2  LC|no2016094511‏
996 ‎‡2  LC|n 2001097442‏
996 ‎‡2  ISNI|0000000078261105‏
996 ‎‡2  SUDOC|224779117‏
996 ‎‡2  SUDOC|174785887‏
996 ‎‡2  BIBSYS|1062295‏
996 ‎‡2  NYNYRILM|2900‏
996 ‎‡2  LC|no2011020763‏
996 ‎‡2  NTA|070338353‏
996 ‎‡2  SUDOC|230267459‏
996 ‎‡2  LC|n 78092186‏
996 ‎‡2  SUDOC|225437325‏
996 ‎‡2  ISNI|0000000116919474‏
996 ‎‡2  LC|no2008184966‏
996 ‎‡2  ISNI|0000000039288305‏
996 ‎‡2  BIBSYS|1592544499533‏
996 ‎‡2  NSK|000478459‏
996 ‎‡2  BIBSYS|90689735‏
996 ‎‡2  LC|nr 94043765‏
996 ‎‡2  ISNI|0000000390350022‏
996 ‎‡2  LC|n 88232964‏
996 ‎‡2  DNB|1048607658‏
996 ‎‡2  NII|DA08009111‏
996 ‎‡2  LC|nb 99050707‏
996 ‎‡2  BIBSYS|8031420‏
996 ‎‡2  ERRR|12699615‏
996 ‎‡2  ISNI|0000000030191128‏
996 ‎‡2  LC|n 88045858‏
996 ‎‡2  ISNI|0000000383227528‏
996 ‎‡2  ISNI|0000000424831327‏
996 ‎‡2  SUDOC|149231660‏
996 ‎‡2  SUDOC|079317405‏
996 ‎‡2  CAOONL|ncf12129036‏
996 ‎‡2  DNB|115844995X‏
996 ‎‡2  ISNI|0000000387887494‏
996 ‎‡2  ISNI|0000000033799606‏
996 ‎‡2  ISNI|0000000123960571‏
996 ‎‡2  NDL|001144696‏
996 ‎‡2  NUKAT|n 2018123065‏
996 ‎‡2  LIH|LNB:CIJG;=_w_C‏
996 ‎‡2  ISNI|0000000069207238‏
996 ‎‡2  DNB|132705818‏
996 ‎‡2  BNF|16238715‏
996 ‎‡2  BNF|12344884‏
996 ‎‡2  LC|n 2019064418‏
996 ‎‡2  SUDOC|248616196‏
996 ‎‡2  NLA|000035607573‏
996 ‎‡2  NDL|00820591‏
996 ‎‡2  SUDOC|067278213‏
996 ‎‡2  DNB|117349496‏
996 ‎‡2  ISNI|0000000027353587‏
996 ‎‡2  ISNI|0000000034778145‏
996 ‎‡2  NUKAT|n 2020210436‏
996 ‎‡2  J9U|987007322164605171‏
996 ‎‡2  BIBSYS|1634281490897‏
996 ‎‡2  NUKAT|n 2011109229‏
996 ‎‡2  BNF|11568175‏
996 ‎‡2  NUKAT|n 2002068257‏
996 ‎‡2  SUDOC|190042508‏
996 ‎‡2  ISNI|0000000104285435‏
996 ‎‡2  ISNI|0000000116119661‏
996 ‎‡2  BIBSYS|1071394‏
996 ‎‡2  DNB|1062266668‏
996 ‎‡2  JPG|500354898‏
996 ‎‡2  SELIBR|fxp0q49xcwfs2mbz‏
996 ‎‡2  KRNLK|KAC199627389‏
996 ‎‡2  LC|nb2009007956‏
996 ‎‡2  SUDOC|070523436‏
996 ‎‡2  SUDOC|257965580‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏